Dr Reddys Laboratories (RDY) Divestments (2009 - 2026)

Dr Reddys Laboratories has reported Divestments for 17 years, with the latest figure at $52813.8 in Q2 2026.

• On a quarterly basis, Divestments rose 100.02% year-over-year to $52813.8 in Q2 2026; TTM through Jun 2026 was -$621.2 million, a 8.09% increase from a year earlier, with the FY2023 full-year figure at -$5.7 million, changed N/A from the prior year.
• Divestments was $52813.8 for Q2 2026 at Dr Reddys Laboratories, up from -$224.3 million in the prior quarter.
• The five-year high for Divestments was $305.8 million in Q1 2023, with the low at -$321.7 million in Q4 2022.
• Average Divestments over 5 years is -$78.4 million, with a median of -$82.0 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2026: Divestments sank 772.92% in 2022, then soared 100.02% in 2026.
• Over 5 years, Divestments stood at -$321.7 million in 2022, then soared by 52.03% to -$154.3 million in 2023, then plunged by 57.32% to -$242.7 million in 2024, then gained by 7.61% to -$224.3 million in 2025, then soared by 100.02% to $52813.8 in 2026.
• The last three Divestments figures came in at $52813.8 (Q2 2026), -$224.3 million (Q2 2025), and -$242.7 million (Q2 2024), per Business Quant data.